SJS Investment Consulting Inc.
Position in TNXP — Tonix Pharmaceuticals Holding Corp.
CIK 1894302
SYLVANIA, OH
Position in TNXP
as of Mar 31, 2026
· filed Apr 23, 2026
Position Value
$137,555
New position
Shares Held
10,004
first reported quarter
Ownership
0.063%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Mar 31, 2026SJS Investment Consulting Inc. holds $651,484 across 108 Biotechnology names. TNXP ranks #2 (21.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
795 | $150,294 | |
| 2 | TNXP |
Tonix Pharmaceuticals Holding Corp.
This page
|
10,004 | $137,555 | |
| 3 | SLS |
SELLAS Life Sciences Group, Inc.
|
25,000 | $105,750 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
66 | $50,994 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
705 | $39,825 | |
| 6 | EXEL |
Exelixis, Inc.
|
655 | $28,092 | |
| 7 | TECH |
BIO-TECHNE Corp
|
342 | $17,872 | |
| 8 | MIST |
Milestone Pharmaceuticals Inc.
|
15,000 | $17,850 |
All Filings in TNXP
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $137,555 | 10,004 | Shares | Sole | 2026-04-23 | |
| No filing history on record for this holder in this stock. | ||||||